Assembly Biosciences, INC. (ASMB) — 8-K Filings

8-K Filings (18)

• 8-K Filing — Dec 8, 2025
• Assembly Biosciences Files 8-K on Key Agreements and Equity Sales — Aug 11, 2025 Risk: medium
  Assembly Biosciences, Inc. filed an 8-K on August 11, 2025, reporting on events that occurred on August 8, 2025. The filing indicates an entry into a material d
• Assembly Biosciences Files 8-K — Aug 8, 2025 Risk: low
  Assembly Biosciences, Inc. filed an 8-K on August 8, 2025, reporting on other events and financial statements. The filing does not contain specific financial fi
• Assembly Biosciences Files 8-K — Jun 25, 2025 Risk: low
  Assembly Biosciences, Inc. filed an 8-K on June 25, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not detail specific
• Assembly Biosciences Reports Director/Officer Changes & More — Jun 9, 2025 Risk: medium
  Assembly Biosciences, Inc. filed an 8-K on June 9, 2025, reporting on events that occurred on June 5, 2025. The filing covers the departure of directors or cert
• Assembly Biosciences Files 8-K — Feb 20, 2025 Risk: low
  Assembly Biosciences, Inc. filed an 8-K on February 20, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain spec
• Assembly Biosciences Files 8-K on Material Agreement — Jan 3, 2025 Risk: medium
  Assembly Biosciences, Inc. filed an 8-K on January 3, 2025, reporting a material definitive agreement and a direct financial obligation entered into on December
• Assembly Biosciences Files 8-K — Dec 26, 2024 Risk: low
  Assembly Biosciences, Inc. filed an 8-K on December 26, 2024, reporting other events and financial statements. The company, formerly known as Ventrus Bioscience
• Assembly Biosciences Files 8-K on Material Agreement — Dec 19, 2024 Risk: medium
  On December 19, 2024, Assembly Biosciences, Inc. filed an 8-K report detailing a material definitive agreement. The filing also covers unregistered sales of equ
• Assembly Biosciences Files 8-K with Corporate Updates — Dec 13, 2024 Risk: low
  Assembly Biosciences, Inc. filed an 8-K on December 12, 2024, reporting amendments to its Articles of Incorporation or Bylaws and filing financial statements an
• Assembly Biosciences Files 8-K — Sep 23, 2024 Risk: low
  Assembly Biosciences, Inc. filed an 8-K on September 23, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain spe
• Assembly Biosciences Enters Material Agreement — Jun 18, 2024 Risk: medium
  Assembly Biosciences, Inc. announced on June 16, 2024, that it entered into a Material Definitive Agreement. The company also reported on unregistered sales of
• Assembly Biosciences Ditches HBV Program, Cuts 45% Workforce — Jun 3, 2024 Risk: high
  Assembly Biosciences, Inc. announced on May 29, 2024, a strategic decision to discontinue its Hepatitis B virus (HBV) program, including its lead drug candidate
• Assembly Biosciences Files 8-K on Operations — Mar 28, 2024 Risk: low
  Assembly Biosciences, Inc. filed an 8-K on March 28, 2024, reporting on its results of operations and financial condition, as well as financial statements and e
• Assembly Biosciences Appoints New CEO, CMO, CFO — Mar 15, 2024 Risk: medium
  Assembly Biosciences, Inc. announced on March 12, 2024, a series of significant leadership changes. Dr. Henry "Hank" Alfred, Jr. has been appointed as the new C
• Assembly Biosciences Reports Bylaw & Security Holder Rights Changes — Feb 13, 2024 Risk: medium
  ASSEMBLY BIOSCIENCES, INC. filed an 8-K on February 13, 2024, reporting events that occurred on February 8, 2024. The filing indicates material modifications to
• ASMB Files 8-K on Shareholder Vote & Other Events — Feb 2, 2024
  Assembly Biosciences, Inc. filed an 8-K on February 2, 2024, reporting an event that occurred on January 31, 2024. This filing indicates that the company submit
• ASMB Terminates Material Agreement, Signals Strategic Shift — Jan 17, 2024
  Assembly Biosciences, Inc. (ASMB) filed an 8-K on January 17, 2024, reporting the termination of a material definitive agreement, effective January 11, 2024. Th

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX